P39 Patient-Reported Outcomes As Endpoint in Oncology Trials: An Analysis of FDA and EMA Claims
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.051
https://www.valueinhealthjournal.com/article/S1098-3015(23)00151-1/fulltext
Title :
P39 Patient-Reported Outcomes As Endpoint in Oncology Trials: An Analysis of FDA and EMA Claims
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00151-1&doi=10.1016/j.jval.2023.03.051
First page :
Section Title :
Open access? :
No
Section Order :
11854